Drug Topics June 6, 2024
HbA1c levels decreased significantly after an average of 154 days in patients who used a continuous glucose monitor.
A continuous glucose monitoring (CGM) optimization program can help patients with diabetes become more self-aware and give health care providers additional insight into glycemic control, according to new research presented at the Endocrine Society’s 2024 annual meeting, held June 1 to 4 in Boston, Massachusetts.1
According to data from the CDC, nearly 40 million people in the United States have a diagnosed case of diabetes.2 Complication from the disease can include microvascular, macrovascular, and neuropathic issues, which is why managing the condition is crucial to improving outcomes. CGM is a key tool in managing diabetes, as it provides a comprehensive and detailed...
Today's Sponsors
Today's Sponsor